Publication: Experience with ustekinumab in reservoir Crohn's disease.
No Thumbnail Available
Identifiers
Date
2022-04-07
Authors
Martinez-Burgos, Maria
Angulo-McGrath, Isabela
Amo-Trillo, Victor
Olmedo-Martin, Raul
Romero-Caro, Patricia
Mostazo-Torres, Jose
Jimenez-Perez, Miguel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Sociedad Española de Patologia Digestiva
Metrics
Export
Abstract
Crohn's disease of the reservoir is a pathology of difficult diagnosis and complex approach due to the scarce documented evidence on it. Recently, studies have been published on the treatment strategies available for this entity. Based on the above, we have analyzed the experience of our center in the treatment of reservoir Crohn's disease with one of the new biologic agents, ustekinumab.
Description
MeSH Terms
Humans
Remission Induction
Treatment Outcome
Ustekinumab
Remission Induction
Treatment Outcome
Ustekinumab
DeCS Terms
Reservorios de Agua
Enfermedad de Crohn
Productos Biológicos
Síndrome de Inmunodeficiencia Adquirida
Enfermedad de Crohn
Productos Biológicos
Síndrome de Inmunodeficiencia Adquirida
CIE Terms
Keywords
Crohn Disease, Water Reservoirs, Biological Products
Citation
Martínez Burgos M, Angulo McGrath I, Amo Trillo V, Olmedo Martín R, Romero Caro P, Mostazo Torres J, et al. Experience with ustekinumab in reservoir Crohn's disease. Rev Esp Enferm Dig. 2022 Apr;114(4):233-234